We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current IVRO market cap is 1.82M. The company's latest EPS is USD 0.0001 and P/E is 800.00.
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.05M | 1.11M | 1M | 854k | 793k |
| Operating Income | 62k | 32k | -27k | -117k | -25k |
| Net Income | 71k | 50k | 96k | 21k | 2k |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.38M | 1.54M | 1.63M | 1.51M | 1.53M |
| Total Liabilities | 154k | 212k | 202k | 68k | 79k |
| Total Equity | 1.23M | 1.33M | 1.43M | 1.44M | 1.46M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 138k | -22k | 32k | 40k | -58k |
| Investing | -87k | -36k | 12k | 685k | -817k |
| Financing | N/A | 107k | 101k | -15k | N/A |
| Market Cap | 1.82M |
| Price to Earnings Ratio | 800.00 |
| Price to Sales Ratio | 2.3 |
| Price to Cash Ratio | 5.1 |
| Price to Book Ratio | 1.25 |
| Dividend Yield | - |
| Shares Outstanding | 22.76M |
| Average Volume (1 week) | 65.84k |
| Average Volume (1 Month) | 26.09k |
| 52 Week Change | 33.33% |
| 52 Week High | 0.12 |
| 52 Week Low | 0.025 |
| Spread (Intraday) | 0.03 (25.73%) |
| Company Name | Invitro International (QB) |
| Address |
330 e. orangethorpe avenue placerville, california 92870 |
| Website | https://www.invitrointl.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
